drugset / Trial / NCT02011633

Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 500mg and Rosuvastatin 10mg

NCT02011633

Phase 1 Completed 72 enrolled Hanmi Pharmaceutical Company Limited
RandomizedCrossoverOpen-labelTreatment

Summary

To compare the pharmacokinetic characteristics between HCP1201 tablet 500/10 mg and co-administration of metformin 500 mg plus rosuvastatin 10 mg under fasted and fed state, respectively.

Timeline

Start
2013-10
Primary completion
2013-11
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Subject HCP1201 Unknown 10 mg Oral
Subject HCP1201 Unknown 500 mg Oral
Comparator Metformin Small molecule 500 mg Oral
Comparator Rosuvastatin Small molecule 10 mg Oral

Indications